NEURO360 partner, Avadel Pharmaceuticals, is expanding its sleep medicine pipeline with a new potential therapy, valiloxybate for treatment of narcolepsy and idiopathic hypersomnia.
Read the press release at Avadel Pharmaceuticals’ website by clicking here.
